HOCl Wound Irrigation System, per-patient bag and single-use head (Aquaceso; variant)

The bet

A wound nurse cleans a chronic wound at each dressing change. She may work in a US hospital, an outpatient wound clinic, a skilled nursing facility, or on a home health visit. Today she uses saline and a syringe, or pours from a bottle or bag of an HOCl cleanser that is already cleared claim 6verified. The bet is that her employer will buy a system instead. It has two parts:

Evidence

The claim ledger →

First in the assessment's queue

1. highB1 Hospitals, wound clinics, nursing homes and home-care agencies in the United States must pay more for each cleaning session with this system than for saline and a syringe. They pay from their own supply budgets, because no insurer pays for it separately, and the price has to cover what a session costs to make. If they will not pay more, nothing here earns money.

   Precisely: US hospitals, outpatient wound clinics, skilled nursing facilities and home health agencies, buying out of a supply budget that sits inside a bundled payment and with no separate Medicare payment for the product, pay a per-session price for one single-use head plus its share of a per-patient bag that is above saline with a syringe or a bottle of HOCl cleanser, and that price covers the fully loaded cost of a session at the business case's volume and at one-tenth of it

   fatal if false
   cheap to find out
   Adjacent cases — 0 found elsewhere

   Requested, not back yet: Who has sold a single-use, maker-specific irrigation or wound-care accessory into US facility supply budgets at a premium over a commodity comparator, with no separate payment

   What happened somewhere else. Not evidence for this bet until a line is copied into the claims and the Verifier passes it.

2. highB2 The single-use spray head has to fit only this maker's bag, and the bag's port has to seal itself between sessions. The United States regulator has to accept a connector that is not the standard one, and hospital buyers have to accept a head that will not fit the bags they already stock. If any of that fails, the head becomes an accessory for anyone's bag and the bag has to sell on its own, which is a different business.

   Precisely: The single-use head is keyed to this maker's bag, and buyers accept it. One connector can be made that accepts only this maker's head, reseals between sessions, and is acceptable to FDA (US Food and Drug Administration) within a 510(k) (premarket notification) or exempt route. US value-analysis committees and group purchasing buyers put on formulary a head that fits only its own maker's bag, and do not require it to fit bags they already stock

   reshaping if false
   cheap to find out
3. moderateB8 In Denmark and the rest of Europe, the bag should fall in the second-highest of the four device risk classes rather than the highest. Danish regional tenders should let the bag and the head bid separately and score more than price, and no European patent should block the product. None of this has been checked against a primary source, because the tools here reach only American records. If it fails, Denmark comes later or costs more, and the American plan is unchanged.

   Precisely: The referrer's home market is open. Under EU MDR (medical device report) Annex VIII, an HOCl irrigation solution with HOCl as a preservative is Class IIb, not Class III (FDA device class III), with a notified-body precedent. Danish regional tenders, Region Nordjylland's being the one in the file, admit the bag on its own and a head on its own, and weigh at least one criterion other than price. No European patent in force in Denmark reads on the head, the shield, the solution or the system

   costly if false
   cheap to find out

The whole assessment →

The chairs

7 of 7 departments have stated a position. The argument →

Still open

• 38 open question(s) between departments

What a decision does

• Approve sets status: shortlisted — the only thing that lets /diligence start.
• Reject or defer is recorded with your note; nothing further is unlocked.